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Abstract Pregnancy in women with rheumatic disorders is
known to be associated with risks for both the mother and
fetus; however, these risks can beminimized with proper plan-
ning and careful management of the disease. In the Middle
East, there are specific cultural challenges that may have a
negative impact on the care that women with rheumatic dis-
orders receive. There is a need for cross-collaboration between
specialist physicians, improved awareness of rheumatic disor-
ders among the general public and more open discussion with
patients about the potential complications of pregnancy.
Women in the region are often unwilling to discuss their dis-
ease with their partner and are even less likely to seek advice
regarding family planning from their physician. The objective
of this review is to highlight the specific challenges of preg-
nancy management and to discuss why establishing specialist
pregnancy clinics for women with rheumatic disorders could
be an effective solution. Such clinics can provide high quality
care before, during and after pregnancy as shown in several
European and US centers. Additionally, such clinics could be
useful for the collection of pregnancy outcomes data from the
Middle East, which may currently be lacking in the region, in
order to highlight where further improvements can be made.
With specialist care and analysis of pregnancy outcomes, the
standard of care for women with rheumatic disorders in this
area could be significantly improved.
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Introduction
Autoimmune disorders, in particular systemic inflammatory
rheumatic diseases (including rheumatoid arthritis [RA], an-
kylosing spondyloarthritis [AS], systemic lupus erythemato-
sus [SLE], antiphospholipid syndrome [APS] and systemic
sclerosis), affect many women, often during childbearing
age [1]. Numerous studies have shown that pregnancies in
patients with rheumatic diseases are high risk, because of the
potential for complications during periods of active disease
[2]. Several studies have shown that pregnancy in these
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patients is associated with poor fetal outcomes [3–5]; for ex-
ample, higher perinatal mortality rate was observed in mothers
with chronic inflammatory arthritides, related to first birth [6].
In previous decades, female patients were sometimes advised
against pregnancy due to the risk of disease flares and possible
harmful effects of medications on the growing fetus and the
newborn child [5]. However, the current opinion is that
successful and safe pregnancies are possible if pre-
pregnancy planning and screening for maternal and fetal
risks are undertaken, and pregnancy takes place while the
disease is well controlled [2, 5]. Recent studies have
shown improved pregnancy outcomes when pregnancies
were planned and managed at specialized high-risk preg-
nancy clinics [7, 8].
The negative impact of rheumatic diseases on pregnan-
cy outcomes in the Middle East may be greater than else-
where [9]. In Saudi Arabia, a retrospective evaluation of
all pregnancies that occurred in patients with SLE from
1980 to 2006 showed that the proportion of live births
was significantly lower (70.2 vs. 85.7 %), and more likely
to end in fetal deaths (29.7 vs. 14.2 %) and preterm births
(26.7 vs. 5.8 %), in pregnancies occurring after SLE onset
than those occurring before [10]. In Egypt, a prospective
study reported data on 37 pregnancies in 34 patients with
SLE from 2007 to 2009; there were 5 spontaneous mis-
carriages and 32 pregnancies resulted in live births. How-
ever, these births had considerable complications (12 pre-
term babies; 8 with intrauterine growth restriction; 7 with
low birth weight; 6 preterm infants admitted to neonatal
intensive care unit, and 4 neonates died) [11]. Pregnancy
complications were also reported in a retrospective analy-
sis from 2011 [3]. These observations suggest that there is
a need to improve the care and support of pregnant wom-
en with rheumatic diseases in the Middle East in order to
improve pregnancy outcomes in these patients.
Introducing specialized pregnancy care for women with
rheumatic disease is challenging in any country, but physi-
cians in the Middle East face specific challenges that are re-
lated to the culture and healthcare systems that prevail in this
region. In Qatar, a pregnancy and rheumatic disease clinic was
established in 2005. This receives early referrals from rheu-
matologists and obstetricians, potentially leading to improved
outcomes. Establishing specialized pregnancy clinics that are
adjusted to the clinical practice in each country could help to
provide improved care for pregnant patients.
Based on the experiences of practicing rheumatologists in
the Middle East (Saudi Arabia, Egypt, Kuwait, Qatar, United
Arab Emirates [UAE] and Lebanon), the objective of this
review is to identify the challenges that physicians in the Mid-
dle East face when managing patients with rheumatic disor-
ders who are pregnant or of childbearing age, and to discuss
how addressing these challenges could help to improve out-
comes for patients and their babies.
Challenges in the Middle East
In the majority of Middle Eastern countries, there is a lack of
awareness of rheumatic diseases, as well as their pregnancy-
associated complications in the general population. This leads
to delayed diagnosis and delayed initiation of treatment [12].
For example, it is not uncommon for a patient to see a rheu-
matologist for the first time during pregnancy despite having
prior disease managed by physicians of different specialties
(such as internists, orthopedics and family physicians). Fur-
thermore, lack of expertise regarding rheumatic diseases in
other specialties can lead to misleading information and inap-
propriate therapeutic interventions.
Parallel healthcare systems may also introduce treatment
disparities between patients. For example, in the UAE, there
is coexistence of private and public healthcare systems: free
public healthcare facilities are available predominantly to the
local Emirati population while the expatriate population pre-
fers to use private healthcare. In the private healthcare sector,
there can be some reluctance from rheumatologists to refer
women to pregnancy clinics. In the majority of Middle East
countries, both the private and public healthcare systems are
coexistent, which can lead to a financial barrier to referral,
preventing pregnant patients from receiving optimal care.
An issue that is specific to the private healthcare sector is
that there are also inconsistencies in the private health policies
provided by different insurance companies and plans. The
coverage for chronic conditions, autoimmune diseases, pre-
existing diseases, immunotherapy and maternity care vary
among different policies. In addition, there are complexities
in guidelines followed by various insurance payers; these are
often based on clinical guidelines (such as The European
League Against Rheumatism [EULAR] or National Institute
for Health and Care Excellence [NICE] guidelines), but are
influenced by individual policy terms and conditions. Inci-
dences have occurred where pregnant women have been un-
able to receive the required medical care due to exclusion
criteria in their health policies. Furthermore, some patients
cannot affordmedical costs and are therefore deprived ofmed-
ical care. These factors pose major challenges in providing
optimal care.
Furthermore, it is uncommon for women in the Middle
East to seek medical advice while preparing to conceive
[13]. For example, participants in a qualitative study of Qatari
women’s health beliefs stated that it is not socially acceptable
for unmarried women to seek any advice related to pregnancy
[14]. Additionally, there is a lack of general health education
in some districts. A review of the demographic characteristics
of 150 RA patients from five countries in the Middle East
found that 34 % of patients (male and female) had either
received no formal education or only primary school educa-
tion [15]. This lack of education can result in misunderstand-
ings; for example, some women believe that their disease will
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improve when they get married or become pregnant, and as
such they do not believe that they need to discuss the possible
impact of their disease with their husbands.
Another custom is reluctance to inform the future husband
about pre-existing chronic conditions due to fear of marriage
cancellation, which could result in delayed access to care in
the case of an acute flare during pregnancy. Furthermore, the
husband and/or the families can have an influence on the
decision of the couple to become pregnant and the timing of
the pregnancy. This may eventually interfere with the desire of
the couple to seek medical advice when deciding to conceive.
There are a limited number of established patient organisa-
tions or support groups within the Middle East, meaning that
many women are unaware of the symptoms and the course of
rheumatic diseases, and it has been proposed that an educa-
tional program to increase public awareness of rheumatic dis-
eases and the spectrum of rheumatology could encourage pa-
tients to seek advice with their primary care provider [9] and
specialists before planning a pregnancy.
Data gaps and unmet needs
Currently, there are no collaborations for the collation of data
on pregnancy outcomes in the Middle East. Furthermore,
there is a lack of epidemiological data regarding rheumatic
diseases in general except from the work of the Global Burden
of Diseases Working Group [16], and the absence of country-
based data can also be a barrier to implementing treatment
guidelines for the management of RA [9]. It is important to
track pregnancy outcomes of patients with rheumatic diseases
to enable comparison with those of the general population so
that areas for improvement can be identified. Gathering local
epidemiological and health economic data could help to
change the perception that RA, and other inflammatory dis-
eases, are low-priority diseases compared with other condi-
tions believed to be more prevalent in the region [9]. It could
also raise awareness of the complications involved for preg-
nancies in women living with these diseases so that coordinat-
ed care could be improved. A collaborative approach is likely
to be the most successful, as pooling resources would help to
ensure that all countries in the area could participate [9].
Due to prevailing healthcare systems, particularly in pri-
vate sectors, it is very challenging to maintain registries. There
is freedom in the private sector to self-refer to specialists and
switch doctors, which can lead to difficulties in collecting
accurate epidemiological data and impair communication
among specialists. In addition, maintenance of registries and
follow-up are difficult due to the large turnover of expatriate
population moving in and out of various countries of the Gulf
Cooperation Council. The lack of patient registries in the re-
gion means that doctors cannot make comparisons between
data from their clinical practice and the literature.
A systematic review and meta-analysis of pregnancy out-
comes in SLE patients gave support for pre-pregnancy
counselling and multispecialty care of these patients [17]. A
greater availability of epidemiological and statistical data
would reinforce the need to establish pregnancy clinics for
patients with rheumatic diseases in the Middle East and would
encourage greater support from hospital management.
In the first instance, a worthwhile research goal would be
tracking pregnancy outcomes in women with rheumatic dis-
eases in the Middle East, which could involve human leuko-
cyte antigen haplotype profiling studies (especially in the
presence of arranged marriage in the Middle East or the tradi-
tion of marriage among relatives, including cousins) or iden-
tifying the regional differences, if any, in pregnancy outcomes
in patients with rheumatic diseases. Examples of centers of
excellence, which have collected pregnancy outcomes data
in women with inflammatory diseases in other countries, in-
clude St Thomas’ Lupus Pregnancy Clinic, London, UK [18];
the National Center of Pregnancy and Rheumatic Disease in
Trondheim, Norway; the LifeQuest Centre for Reproductive
Medicine, Toronto, Canada; the Lupus and APS Center of
Excellence, New York, USA; the Obstetric Rheumatology
Clinic, Birmingham, UK; and the John Hopkins Lupus Cen-
ter, Baltimore, USA [19]. Much of the data collected and
published from these clinics support the main themes of this
report, including the need to counsel women about their op-
tions before they become pregnant, and management of these
patients by a multidisciplinary team.
Key areas in which other studies have collected data in-
clude the following: epidemiological data (including comor-
bidities or complications, and historical outcomes of the moth-
er and infant), medications, maternal outcomes, fetal/infant
outcomes (low birth weight, major congenital malformations,
perinatal mortality) and disease outcomes [6, 11, 4]. These
data could be collected from Middle East clinics via a stan-
dardized data report form, which would capture the range of
predefined outcomes outlined above, and could then feed into
a central research database for further analysis.
Enhancing cross-collaboration between specialists
There is a lack of clear national guidelines or expert consensus
within many countries in the Middle East relating to the man-
agement of patients with rheumatic diseases who are pregnant
or are considering pregnancy (Table 1). However, the guide-
lines that exist in other regions stress the importance of col-
laborative and consistent care for the best possible outcomes.
For example, the UK NICE guidelines for RA state that pa-
tients should have access to a multidisciplinary team that pro-
vide opportunities for discussion of the effect of their disease
on their life [20], such as pregnancy or pre-pregnancy plan-
ning. Issues that can be caused by a lack of cross-collaboration
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Fig. 1 Establishing a pregnancy
clinic: a case study example










Egypt Yes (1 clinic) No No (sporadic reports) Occasional 80,722,000 Not available ∼1200





Kuwait Planning No Kuwait data registry for
RA patients (KRRD)
No 3,250,000 Not available Kuwait Association of
Rheumatology=27c
UAE Yes No Yes (Abu Dhabi) No 9,206,000 Not available 70
Saudi Arabia Planning No No No 28,288,000 Not available 120
Qatar Yes No Data registry for RA
patients
Yes 2,051,000 Not available 12
a Population in 2012. World Health Organization website. Available at: www.who.int (accessed 18/7/14)
b Number of gynecologists and rheumatologists estimated based on personal communication with rheumatologists
c Does not include private practitioners
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include obstetricians designing a pregnancy plan without con-
sulting the rheumatologist, and therefore not considering
the various medications that the patient is taking, or ob-
stetricians recommending cesarean sections for pregnant
patients when such procedures are not indicated. Data
from Norway showed that there was no increase in the
rate of emergency cesarean sections in women with in-
flammatory arthritides above that of the general popula-
tion, demonstrating that elective cesarean sections are of-
ten chosen in anticipation of problems during delivery and
might not be necessary [6]. Cross-collaboration between
specialists is not common in these fields in the Middle
East, which could be due in part to financial motives
and/or a lack of expertise. In Qatar, cross-collaboration is
well established, and most pregnancies are dealt with by a
multidisciplinary team. The presence of a specialized preg-
nancy clinic raises the awareness of other specialists and
may lead to an increase of referrals of pregnant women
with rheumatic disease.
In order to achieve better patient care and improve out-
comes, a centralized process for coordinated management of
pregnant patients with rheumatic diseases would encourage
cross-collaboration. This would potentially involve establish-
ing dedicated regional centres where a standard of care could
be ensured for all patients. The aim should be to ensure that
patients receive consistent advice from all specialties involved
in their care and that women are treated with both their preg-
nancy, or future pregnancy, and their disease inmind. It should
be emphasized that men with rheumatic diseases also need
counselling while considering starting a family as certain
drugs can have an impact on fertility.
Establishing pregnancy clinics for patients
with rheumatic disorders
Ideally, women with rheumatic diseases who become preg-
nant, or who wish to become pregnant, should be seen in
specialized clinics for high-risk pregnancies. A small number
of specialist clinics have been established in hospitals in Qatar
and Saudi Arabia, but the majority of countries in the Middle
East do not yet have these clinics available. The authors of this
report, the majority of whom are rheumatologists practicing in
the Middle East, believe that such clinics would be valuable
additions to their healthcare systems; helping to increase
awareness of rheumatic diseases, and improve patient
counselling and care during pregnancy.
The key challenges to establishing these clinics are cross-
collaboration, education of medical staff and patients, and
support frommanagement. Based on one author’s experience,
problems encountered when establishing a pregnancy clinic in
Trondheim, Norway, included difficulties convincing the hos-
pital management that pregnant patients with rheumatic dis-
ease deserve a specialized service when this may not initially
be cost-effective. While it was easy to persuade primary care
physicians that such a clinic would be helpful, as in general
they did not feel competent to deal with patients with high-risk
pregnancies, convincing other specialists proved to be more
difficult. The key steps that were taken to establish a success-
ful clinic are outlined in Fig. 1. Furthermore, setting up a clinic
in Berne, Switzerland, presented different problems, due to the
different healthcare system in place (public and an extensive
private healthcare system versus a tax-funded public
healthcare system in Norway). The specialists in private
Fig. 2 Considerations for best
practice in consultations for
patients with rheumatic diseases
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practice were reluctant to refer their pregnant patients out of
fear of losing income. In order to address this, the team had to
guarantee that the patient would remain in the specialists’ care
and only have consultations at the clinic for the duration of the
pregnancy.
Consultation best practice
If it is not possible to establish a pregnancy clinic, rheumatol-
ogists and obstetricians can also help to improve the care of
women with rheumatic diseases by following best practice
during consultations with these women (Fig. 2). Pregnancy
and family planning should be discussed routinely with all
women with rheumatic diseases that are of childbearing age,
using language that is suitable for the patient’s level of under-
standing. It should not be assumed that older patients, those
who already have children, or women who have re-married do
not want to have further children.
Women with rheumatic diseases should undergo counsel-
ling before conception for their specific risk profile [5], and
subsequently a management plan should be developed. It is
also important for physicians to respect that it is the patient’s
right to choose to become pregnant, and to support them in
this decision regardless of the physician’s own personal
beliefs.
Where possible, women with rheumatic diseases who
would like to discuss pregnancy should attend medical
appointments with their partners. There is evidence that
the moral support from family members contributes to
an increased use of maternal health services by women
in rural Egypt [21], and, in some regions, women often
have strong beliefs that they must follow the guidance
of their husband rather than their physician. If partners
attend appointments together, misapprehensions can be
discussed and addressed.
It may be helpful for the treating physician to review
other sources of information the patient has accessed in
order to mitigate any harmful misunderstandings or ad-
vice. In the UK, the NICE Quality Standard for RA
[22] recommends that education and self-management
should be employed to improve a patient’s understand-
ing of their disease. Additionally, it states that this ed-
ucation should be offered throughout the disease course
and should be individualized to the patient; therefore,
education offered to women of childbearing age should
include advice about their disease and the possible im-
plications and management strategies during pregnancy.
Although these recommendations are specific to RA,
such considerations could also be applied more widely
to other systemic inflammatory conditions that may im-
pact pregnancy outcomes.
Conclusions
As compared to other parts of the world, cultural and tradi-
tional factors may affect the health system and care of preg-
nant women with rheumatic disease in the Middle East. These
factors should be carefully studied and approached to improve
the standard of care offered to women in this area.
Communication between specialists is essential to ensure
that patients receive the highest standard of care prior to,
throughout and after pregnancy. Cross-collaboration between
specialists should be encouraged and supported by manage-
ment where possible, and establishing specialized pregnancy
clinics in the Middle East region involving these multidisci-
plinary teams could help to ensure the best possible outcomes
for both mother and infant. However, where this is not possi-
ble, the primary goals of physicians should be to ensure that
women with rheumatic diseases receive pre-pregnancy
counselling, are referred appropriately and are supported
throughout pregnancy. The core emphasis should be to in-
crease awareness among the general population of the need
for this service and provide access to the nearest available
specialized pregnancy clinic for women and men with rheu-
matic diseases.
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